Research published in the medical journal JAMA estimates that close to half of all new brand-name prescription drugs launched in the United States in 2020 and 2021 came with an original price tag of at least $150,000 a year, a finding that sparked fresh calls for Congress to rein in the pharmaceutical industry’s virtually unchecked power to drive up costs.